A Large Prospective Volumetric and Patient-Reported Outcome Analysis of Hyaluronic Acid Facial Fillers
- PMID: 40178806
- DOI: 10.1097/PRS.0000000000012135
A Large Prospective Volumetric and Patient-Reported Outcome Analysis of Hyaluronic Acid Facial Fillers
Abstract
Background: Hyaluronic acid (HA) facial fillers are a nonsurgical treatment for age-related changes. Literature on long-term volumetric results and patient-reported outcomes (PROs) is limited. This prospective study aimed to precisely define and measure objective tissue metrics and PROs of HA fillers in different facial regions over 12 weeks.
Methods: Women 40 to 65 years of age received injections in facial regions using HA fillers: Restylane-L in nasolabial folds and marionette lines, Restylane-L Lyft in the malars, and Restylane Silk in the lip border. Patients completed the FACE-Q, and were photographed with 3-dimensional Vectra M3 imaging software before injection, immediately after injection, and at 2, 4, and 12 weeks after injection. Volumes were analyzed from 8 regions: left and right malars and extended midface, upper perioral, lower perioral and jawline, and lips. Tissue displacement factor (TDF) and effective volume (EV) were calculated. Statistical analyses included Mann-Whitney U tests and risk-adjusted linear regression.
Results: A total of 101 women participated. Restylane-L Lyft had the highest TDF (1.25), followed by Restylane-L (1.14) and Restylane Silk (0.56). EV for Restylane-L Lyft was highest (89.8%), followed by Restylane-L (89.7%) and Restylane Silk (70%). Volume maintenance was 65.5% (whole face), 79.2% (malars and extended midface), 62.7% (upper perioral), and 37.2% (lips) over 12 weeks. PROs demonstrated improvements in facial appearance, treated regions, and psychologic and social function.
Conclusions: The authors defined novel tissue metrics-TDF and EV-relative to HA treatments, with greatest volume maintenance in the midface and greatest loss around the mimetic areas through 12 weeks. Significantly improved PROs were observed for patients undergoing large-volume HA filler injections.
Clinical question/level of evidence: Therapeutic, IV.
Trial registration: ClinicalTrials.gov NCT03460158.
Copyright © 2025 by the American Society of Plastic Surgeons.
References
-
- Boehm LM, Morgan A, Hettinger P, Matloub HS. Facial aging: a quantitative analysis of midface volume changes over 11 years. Plast Reconstr Surg. 2021;147:319–327.
-
- Akinbiyi T, Othman S, Familusi O, Calvert C, Card EB, Percec I. Better results in facial rejuvenation with fillers. Plast Reconstr Surg Glob Open 2020;8:e2763.
-
- American Society of Plastic Surgeons. Plastic surgery statistics report 2020. Available at: https://www.plasticsurgery.org/documents/news/statistics/2020/plastic-su... .
-
- Talarico S, Meski AP, Buratini L, et al. High patient satisfaction of a hyaluronic acid filler producing enduring full-facial volume restoration: an 18-month open multicenter study. Dermatol Surg. 2015;41:1361–1369.
-
- Bertucci V, Nikolis A, Solish N, Lane V, Hicks J. Subject and partner satisfaction with lip and perioral enhancement using flexible hyaluronic acid fillers. J Cosmet Dermatol. 2021;20:1499–1504.
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
